home / stock / zom / zom news

ZOM News and Press, Zomedica Pharmaceuticals Corp. From 03/07/24

Stock Information
Company Name: Zomedica Pharmaceuticals Corp.
Stock Symbol: ZOM
Market: NYSE
Website: zomedica.com
Menu
ZOM ZOM Quote ZOM Short ZOM News ZOM Articles ZOM Message Board
Get ZOM Alerts

News, Short Squeeze, Breakout and More Instantly...
ZOM - Zomedica Announces Publication of Case Series Highlighting Success with PulseVet(R) Shock Wave Therapy for Difficult to Treat Fibrotic Myopathy in Working Dogs

ANN ARBOR, MI / ACCESSWIRE / March 7, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for equine and companion animals, today announced the publication of a case series article suppor...
ZOM - Zomedica to Present at the Sidoti Small Cap Conference March 14, 2024

ANN ARBOR, MI / ACCESSWIRE / March 5, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for equine and companion animals, today announced that Larry Heaton, Chief Executive Officer, wil...

ZOM - 3 High-Reward Penny Stocks to Uncover Big Gains

2024-02-11 11:22:43 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Due to the fact that the stock market is in a constant state of flux, high-reward penny stocks often surface as hidden gems, luring purchasers with the promise of substantial rewards. Inves...

ZOM - Zomedica Announces Sponsorship of Educational Presentations at Major Veterinary Health Conferences

ANN ARBOR, MI / ACCESSWIRE / February 8, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostic and therapeutic products for equine and companion animals, today announced the continuation of its veterinary education ...
ZOM - Leading Independent Proxy Advisory Firm Glass Lewis Recommends Zomedica Shareholders Vote for the Share Consolidation (Reverse Stock Split)

ANN ARBOR, MI / ACCESSWIRE / February 6, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostic and therapeutic products for equine and companion animals, today announced that Glass Lewis, a leading independent pro...

ZOM - Zomedica to Host Virtual Investor Day February 13 at 3:00 p.m. ET

ANN ARBOR, MI / ACCESSWIRE / February 6, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostic and therapeutic products for equine and companion animals, today announced that it will be hosting a Virtual Investor ...

ZOM - Open Letter to Zomedica Shareholders from your Chief Executive Officer

ANN ARBOR, MI / ACCESSWIRE / January 31, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for equine and companion animals, today announced that Chief Executive Officer Larry Heaton ...
ZOM - Zomedica to Participate in the Lytham Partners 2024 Investor Select Conference

ANN ARBOR, MI / ACCESSWIRE / January 30, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for equine and companion animals, today announced that Larry Heaton, Chief Executive Officer...

ZOM - Leading Proxy Advisory Firm ISS Recommends Zomedica Shareholders Vote "FOR" Proposed Reverse Stock Split

ANN ARBOR, MI / ACCESSWIRE / January 25, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for equine and companion animals, today announced that Institutional Shareholder Services ("IS...

ZOM - Zomedica says Q4 revenue is expected to be over $7M

2024-01-17 16:25:08 ET More on Zomedica Zomedica Corp. (ZOM) Q3 2023 Earnings Call Transcript Financial information for Zomedica For further details see: Zomedica says Q4 revenue is expected to be over $7M
Previous 10 Next 10